Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
Sales | 4,767,000 | 4,889,000 | 4,532,000 | 5,157,000 | 4,778,000 |
Cost of Goods | 1,483,000 | 1,483,000 | 1,367,000 | 1,665,000 | 1,467,000 |
Gross Profit | 3,284,000 | 3,406,000 | 3,165,000 | 3,492,000 | 3,311,000 |
Operating Expenses | 2,342,000 | 2,387,000 | 2,179,000 | 2,481,000 | 2,156,000 |
Operating Income | 942,000 | 1,019,000 | 986,000 | 1,011,000 | 1,155,000 |
Other Income | 684,000 | 111,000 | -58,000 | 28,000 | -9,000 |
Pre-tax Income | 1,626,000 | 1,130,000 | 928,000 | 1,039,000 | 1,146,000 |
Income Tax | 507,000 | -21,000 | 268,000 | 766,000 | 239,000 |
Net Income Continuous | 964,000 | 991,000 | 538,000 | 139,000 | 755,000 |
Net Income Discontinuous | N/A | 13,000 | -5,000 | N/A | 3,000 |
Net Income | $964,000 | $1,004,000 | $533,000 | $139,000 | $758,000 |
EPS Basic Total Ops | 0.49 | 0.51 | 0.27 | 0.07 | 0.39 |
EPS Basic Continuous Ops | 0.49 | 0.51 | 0.27 | 0.06 | 0.39 |
EPS Basic Discontinuous Ops | N/A | 0.01 | 0.00 | 0.00 | 0.00 |
EPS Diluted Total Ops | 0.49 | 0.50 | 0.27 | 0.07 | 0.38 |
EPS Diluted Continuous Ops | 0.49 | 0.50 | 0.27 | 0.06 | 0.38 |
EPS Diluted Discontinuous Ops | N/A | 0.01 | 0.00 | 0.00 | 0.00 |
EBITDA(a) | $1,159,000 | $1,249,000 | $1,229,000 | $1,266,000 | $1,393,000 |